ICoLA 2019

Date	Time	Room	Session/Title	Presentation Time	Presentation Title	Role
Sep. 5 (Thu.)	16:00-17:30	Room 5	Symposium 2 / Reappraisal of Immune Cells in Cardiovascular Disease	16:20-16:40	Macrophage Immunometabolism in Heart	Chairperson
Sep. 5 (Thu.)	16:00-17:30	Room 5	Symposium 2 / Reappraisal of Immune Cells in Cardiovascular Disease	16:20-16:40	Macrophage Immunometabolism in Heart	Chairperson

BREAKFAST SYMPOSIUM 4 [Yooyoung]: Sep.11(Sat.)

Chairperson In-Kyung Jeong (Kyung Hee University, Korea)

08:00-08:20	Interim analysis of APOLLO Study: 2 years follow-up results Seung-Woon Rha (Korea University, Korea)
08:20-08:30	Discussion

BREAKFAST SYMPOSIUM 5 [Chong Kun Dang]: Sep.11(Sat.)

Chairperson Moon-Kyu Lee (Eulji University, Korea)

08:00-08:20	How to manage vascular health with statin in Korean patient: evidence based medicine LIPILOU Jong-Young Lee (Sungkyunkwan University, Korea)
08:20-08:30	Discussion

BREAKFAST SYMPOSIUM 6 [Celltrion/Jeil Pharmaceutical]: Sep.11(Sat.)

Chairperson Eun-Jung Rhee (Sunkyunkwan University, Korea)

08:00-08:20	CV safety of Alogliptin in T2DM patients Jae Hyoung Park (Korea University, Korea)
08:20-08:30	Discussion

(07:30-08:30): Sep.11(Sat.); 5

Chairpersons (TBD)

: Sep.11(Sat.); Room 1+2+3

Chairperson Joong-Yeol Park (University of Ulsan, Korea)

Hypertriglyceridemia: diagnostic and therapeutic implications Alan Remaley (National Institutes of Health, USA)

BREAK: Sep.11(Sat.)

SYMPOSIUM 14 Recent studies on PCSK9 inhibitors & omega-3 PUFA: Sep.11(Sat.)

Chairpersons Jaetaek Kim (Chung-Ang University, Korea)
Hyun Jae Kang (Seoul National University, Korea)

09:40-10:05	Latest data on siRNA against PCSK9 Masatsune Ogura (Chiba University Graduate School of Medicine, Japan)
10:05-10:30	Patient selection for PCSK9 MAb based therapies Kausik Ray (Imperial College London, UK)
10:30-10:55	Biological effect & clinical benefit of omega-3 PUFA Mi Kyung Kim (Inje University, Korea)
10:55-11:20	Discussion

SYMPOSIUM 15 New treatment agents for dyslipidemia: Sep.11(Sat.)

Chairpersons Dae Jung Kim (Ajou University, Korea)
Byung Jin Kim (Sungkyunkwan University, Korea)

09:40-10:05	The metabolic effects of antisense oligonucleotides treatments in dyslipidemia Gissette Reyes-Soffer (Columbia University, USA)
10:05-10:30	Emerging targets for management of dyslipidemia Hun-Jun Park (The Catholic University of Korea, Korea)
10:30-10:55	New PPARalpha agonist Sang Yong Kim (Chosun University, Korea)
10:55-11:20	Discussion

SYMPOSIUM 16 Update on lipoprotein metabolism & regulation: Sep.11(Sat.)

Chairpersons Ki Hoon Han (University of Ulsan, Korea)
In-Kyung Jeong (Kyung Hee University, Korea)

09:40-10:05	Apolipoprotein C3 as a regulator of triglyceride-rich lipoproteins in diabetes and its complications Jenny E. Kanter (University of Washington, USA)
10:05-10:30	What's new in intracellular lipid trafficking Young Mi Park (Ewha Womans University, Korea)
10:30-10:55	Regulation of microsomal triglyceride transfer protein (MTP) in lipid metabolism Mahmood Hussain (New York University, USA)
10:55-11:20	Discussion

SYMPOSIUM 17 What’s new in lifestyle/nutrition modification: Sep.11(Sat.)

Chairpersons Yangha Kim (Ewha Womans University, Korea)
Eung-Ju Kim (Korea University, Korea)

09:40-10:05	Vitamin D in cardiometabolic disease - the more the better? Yongjoo Park (Chonnam National University, Korea)
10:05-10:30	Systems science in biomedical research regarding obesity and noncommunicable chronic diseases Hong Xue (George Mason University, USA)
10:30-10:55	Nutrition policies to improve diet and reduce health and economic burdens of cardiometabolic diseases: a microsimulation study Yujin Lee (Myongji University, Korea)
10:55-11:20	Discussion

SYMPOSIUM 18 (Joint with JAS) Update on platelet in atherosclerosis & acute coronary syndrome: Sep.11(Sat.)

Chairpersons Young-Bae Park (Seoul National University, Korea)
Youngkeun Ahn (Chonnam National University, Korea)

09:40-10:05	Update on pathophysiology of acute coronary syndrome Hiroyuki Hao (Nihon University, Japan)
10:05-10:30	Topics in the antiplatelet therapy: Daily dose of thienopyridine ADP receptor antagonists in Japan and the effect of thrombocytopenia on the DAPT therapy Hisanori Horiuchi (Tohoku University, Japan)
10:30-10:55	Latest therapeutic strategies to modify platelet function Soon Jun Hong (Korea University, Korea)
10:55-11:20	Discussion

COFFEE BREAK: Sep.11(Sat.)

: Sep.11(Sat.); Room 1+2+3

Chairperson Sang Hong Baek (The Catholic University of Korea, Korea)

Genetics/epigenetic approach in studies of lipid metabolism & atherosclerosis Kiran Musunuru (University of Pennsylvania, USA)

LUNCHEON SYMPOSIUM 5 [Daewoong]: Sep.11(Sat.)

Chairperson Sang Hong Baek (The Catholic University of Korea, Korea)

12:10-12:30	Lower is better & combination is better [Ezetimibe+Rosuvastatin] Soo Heon Kwak (Seoul National University, Korea)
12:30-12:40	Discussion

LUNCHEON SYMPOSIUM 6 [JW Pharmaceutical]: Sep.11(Sat.)

Chairperson Hyun Chul Lee (Yonsei University, Korea)

12:10-12:30	Cutting edge care of Pitavastatin with Ezetimibe combination therapy Ki Hoon Han (University of Ulsan, Korea)
12:30-12:40	DIscussion

LUNCHEON SYMPOSIUM 7 [Hanmi]: Sep.11(Sat.)

Chairperson Jeong Euy Park (Sungkyunkwan University, Korea)

12:10-12:30	Why should we consider Rosuvastatin + Ezetimibe fixed dose combination? Jung-Kyu Han (Seoul National University, Korea)
12:30-12:40	Discussion

LUNCHEON SYMPOSIUM 8 [HK. inno.N]: Sep.11(Sat.)

Chairperson Jeong Taek Woo (Kyung Hee University, Korea)

12:10-12:30	Controlling dyslipidemia and CV risk with Atorvastatin and Ezetimibe Soon Jun Hong (Korea University, Korea)
12:30-12:40	Discussion

ORAL PRESENTATION 3: Sep.11(Sat.)

Chairperson Eun Seok Kang (Yonsei University, Korea)
Soon Jun Hong (Korea University, Korea)

ORAL PRESENTATION 4: Sep.11(Sat.)

Chairperson Jung-Sun Kim (Yonsei University, Korea
Ung Kim (Yeungnam University, Korea)

: Sep.11(Sat.); Room 1+2+3

Chairperson Hyo-Soo Kim (Seoul National University, Korea)

Targeting smooth muscle cell in management of atherosclerotic cardiovascular disease Martin Bennett (University of Cambridge, UK)

COFFEE BREAK: Sep.11(Sat.)

SYMPOSIUM 19 Targeting Lp(a) & inflammation in ASCVD: Sep.11(Sat.)

Chairpersons Seok Won Park (Yonsei University, Korea)
Seung Hwan Han (Gachon Universtiy, Korea)

15:00-15:25	Lp(a) as a risk factor Hiroshi Yoshida (Jikei University School of Medicine, Japan)
15:25-15:50	Recent results on Lp(a) therapeutics Sotirios Tsimikas (University of California San Diego, USA)
15:50-16:15	Anti-inflammatory treatment to reduce CV risk Jung Ho Heo (Kosin University, Korea)
16:15-16:40	Discussion

SYMPOSIUM 20 Current & future treatment for HeFH & HoFH: Sep.11(Sat.)

Chairpersons Jeong Taek Woo (Kyung Hee University, Korea)
Sung Hee Choi (Seoul National University, Korea)

15:00-15:25	Personalized medicine for patients with FH Hayato Tada (Kanazawa University, Japan)
15:25-15:50	Current trend in treatment of HeFH/HoFH Dirk Blom (Hatter Institute for Cardiovascular Research in Africa, South Africa)
15:50-16:15	Upcoming treatment agents for FH Sang-Hyun Kim (Seoul National University, Korea)
16:15-16:40	Discussion

SYMPOSIUM 21 HDL update: Sep.11(Sat.)

Chairpersons Ji Dong Sung (Sungkyunkwan University, Korea)
Sang-Hak Lee (Yonsei University, Korea)

15:00-15:25	Beyond HDL-cholesterol: the search for functional biomarkers of HDL Arnold von Eckardstein (University of Zürich, Switzerland)
15:25-15:50	HDL and the cardiovascular risk in diabetes Tomas Vaisar (University of Washington, USA)
15:50-16:15	What’s new in HDL-modifying therapeutics? Jang Hoon Lee (Kyungpook National University, Korea)
16:15-16:40	Discussion

SYMPOSIUM 22 Role of noncoding RNA in lipid metabolism & vascular disease: Sep.11(Sat.)

Chairpersons Youngmi Kim (Kyung Hee University, Korea)
Sungha Park (Yonsei University, Korea)

15:00-15:25	Function of miR-33a/b in lipid and systemic metabolism Koh Ono (Kyoto University, Japan)
15:25-15:50	Non-coding RNA control of cholesterol metabolism and atherosclerosis Katey Rayner (University of Ottawa, Canada)
15:50-16:15	The role of non-coding RNAs in vascular smooth muscle cells Young-Kook Kim (Chonnam National University, Korea)
16:15-16:40	Discussion

PUBLICATION COMMITTEE SESSION: Sep.11(Sat.)

Chairpersons Jaetaek Kim (Chung-Ang University, Korea)
Jeong-Min Kim (Seoul National University, Korea)

15:00 - 15:20	REvisiting lipids in REtinal diseases : a focused review on age-related macular degeneration and diabetic retinopathy Dong Ho Park (Kyungpook National University, Korea)
15:20 - 15:40	The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews Geun Joo Choi (Chung-Ang University, Korea)
15:40 - 16:00	Effect of breakfast consumption and meal time regularity on nutrient intake and cardiometabolic health in Korean adults Oh Yoen Kim (Dong-a University, Korea)
16:00 - 16:20	Mesenchymal stem cell-mediated therapy of peripheral artery disease is stimulated by a lamin A-progerin binding inhibitor Jae Ho Kim (Pusan National University, Korea)
16:20 - 16:40	Phosphorylation in novel mitochondrial creatine kinase tyrosine residues render cardioprotection against hypoxia/reoxygenation injury Jin Han (Inje University, Korea)

BREAK: Sep.11(Sat.)

CLOSING CEREMONY: Sep.11(Sat.)

Scientific Program